Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective
Bioactive substances, especially shikonin (naphthoquinone), which is extracted from Lithospermum erythrorhizon, have drawn much attention as promising substitutes for preventing cancer malignancy. Shikonin (SK) has displayed a broad spectrum of anticancer activities, such as necroptosis, cell cycle...
Saved in:
Main Authors: | Pratibha Pandey, Sorabh Lakhanpal, K. V. Jamuna, Ajay Singh, Mohammad Abohassan, Moon Nyeo Park, Sang-Won Shin, Han Na Kang, Manaal Zahera, Mohd Saeed, Fahad Khan, Bonglee Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1627124/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways
by: Yongkang Liu, et al.
Published: (2019-12-01) -
Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma
by: Ruyue Jia, et al.
Published: (2025-07-01) -
Isolation of unique fluorinated coumarins from new mexico green chile seeds: a novel green extraction approach and bioevaluation against oxidative stress disorders
by: Ayman Faris Faisal, et al.
Published: (2025-09-01) -
Structure-Based Identification of Natural MTH1 Inhibitors for Breast Cancer Therapy via Molecular Docking and Dynamics Simulations
by: Abdullah S. Alawam, et al.
Published: (2025-05-01) -
Synthesis of new glucosylated derivatives of 1,4-quinones
by: O. P. Bondarchuk
Published: (2014-08-01)